Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World Mammography Market May Double by 2007

By HospiMedica staff writers
Posted on 21 Aug 2001
According to a new analysis by the healthcare group at Frost & Sullivan (World X-Ray Mammography Markets), the total world x-ray market, which reached US$282.5 million in 2000, may rise to $567 million by 2007.

Since the market debut of small-field digital mammography systems in 1997, sales of digital x-ray mammography equipment have been on the rise. By eliminating the need for film and offering increased contrast resolution, a wider dynamic range, a higher signal-to-noise ratio, and real-time image enhancement, digital mammography may improve early breast cancer detection rates. Despite the technologic promise, however, some facilities might be unable to afford digital systems.

"Most facilities that provide mammographic services in Western Europe and North American do so at a net loss,” says Frost & Sullivan medical imaging analyst, Antonio Garcia. "Many facility administrators agree that mammography reimbursements are inadequate given the expense of the equipment and the expertise required to perform mammograms.”

Consolidation within the industry has intensified competition for sales. In 1997, there were 12 companies manufacturing and marketing mammography systems in North America. In 2001, there are only six. Consolidation has been driven by high capital requirements for developing full-field digital mammography coupled with limited demand for the equipment. Smaller companies are under pressure to deliver innovative technologies or risk being pushed out of the marketplace.


Related Links:
Frost & Sullivan
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Digital X-Ray Detector Panel
Acuity G4
Biopsy Software
Affirm® Contrast
Half Apron
Demi

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.